Targeted therapy for metastatic colorectal cancer

Expert Review of Anticancer Therapy
Timothy J PriceJeremy Shapiro

Abstract

Outcomes in metastatic colorectal cancer are improving, with better understanding and use of targeted therapies. Areas covered: A review of the literature and recent conference presentations was undertaken on the topic of systemic treatment of metastatic colorectal cancer. This article reviews the current evidence for targeted therapies in advanced colorectal cancer, including up-to-date data regarding anti-epidermal growth factor receptor (EGFR) and anti-vascular endothelial growth factor (VEGF) agents, the relevance of primary tumor location and novel subgroups such as BRAF mutated, HER2 amplified, and mismatch-repair-deficient cancers. Expert commentary: EGFR-targeted and VEGF-targeted antibodies are now routinely incorporated into treatment strategies for metastatic colorectal cancer (mCRC). The use of EGFR-targeted antibodies should be restricted to patients with extended RAS wild-type profiles, and there is evidence that they should be further restricted to patients with left-sided tumors. Clinically, mCRC can be divided into subgroups based on RAS, BRAF, HER2, and MMR status, each of which have distinct treatment pathways.

References

Jan 1, 1991·Journal of Surgical Oncology. Supplement·M LiseP L Pilati
Aug 29, 2002·Nature·Harith RajagopalanVictor E Velculescu
Dec 6, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christophe TournigandAimery de Gramont
Jun 4, 2004·The New England Journal of Medicine·Herbert HurwitzFairooz Kabbinavar
May 5, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G FolprechtC-H Köhne
Jun 9, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Giuseppe ColucciUNKNOWN Gruppo Oncologico Dell'Italia Meridionale
Jul 19, 2005·Cancer Research·Wade S SamowitzMartha L Slattery
Apr 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce J GiantonioUNKNOWN Eastern Cooperative Oncology Group Study E3200
Jul 17, 2007·Lancet·Matthew T SeymourUNKNOWN National Cancer Research Institute Colorectal Clinical Studies Group
Apr 9, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alberto F SobreroHoward A Burris
Apr 19, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Leonard B SaltzJim Cassidy
Oct 24, 2008·The New England Journal of Medicine·Christos S KarapetisJohn R Zalcberg
Nov 13, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Federica Di NicolantonioAlberto Bardelli
Dec 31, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J Randolph HechtRafael G Amado
Feb 7, 2009·The New England Journal of Medicine·Jolien TolCornelis J A Punt
Mar 3, 2009·The Oncologist·Miriam KoopmanCornelis J A Punt
Apr 3, 2009·The New England Journal of Medicine·Eric Van CutsemPhilippe Rougier
Jul 3, 2009·The New England Journal of Medicine·Jolien TolCornelis J A Punt
Dec 17, 2009·Diseases of the Colon and Rectum·Frank BenedixUNKNOWN Colon/Rectum Carcinomas (Primary Tumor) Study Group
Jun 3, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Niall C TebbuttTimothy J Price
Oct 6, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Marc PeetersJennifer Gansert
Apr 20, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eric Van CutsemFortunato Ciardiello
Jun 8, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Timothy J PriceNiall C Tebbutt
Sep 9, 2011·Science Translational Medicine·Kimio YonesakaPasi A Jänne
Sep 10, 2011·The Lancet Oncology·Michel DucreuxUNKNOWN Fédération Francophone de Cancérologie Digestive (FFCD) 2000–05 Collaborative Group
Mar 8, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D SantiniG Tonini
Mar 27, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Carsten BokemeyerClaus-Henning Köhne
Apr 5, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kjell Magne TveitThoralf Christoffersen
Nov 22, 2012·The Lancet Oncology·Jaafar BennounaUNKNOWN ML18147 Study Investigators
Apr 10, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Le-Chi YeJianmin Xu
Sep 13, 2013·The New England Journal of Medicine·Jean-Yves DouillardScott D Patterson

❮ Previous
Next ❯

Citations

Dec 10, 2019·Journal of Drug Targeting·Halyna KuznietsovaVolodymyr Rybalchenko
Feb 15, 2020·Cancers·Maria Debora De PasqualeEvelina Miele
Dec 24, 2019·Cancer Control : Journal of the Moffitt Cancer Center·Fabio CofanoDiego Garbossa
Oct 4, 2020·Cancers·Imeshi WijetungaP Louise Coletta
Nov 26, 2020·International Journal of Molecular Sciences·Federica BovioMilo Frattini
Apr 7, 2021·Cancer Treatment Reviews·Sophie L GerritseHenk M W Verheul
Apr 14, 2021·The Journal of International Medical Research·Na LiYue Dong Liu
Apr 3, 2021·Gastroenterology·Nicholas J Clemons, Wayne A Phillips
May 25, 2021·Expert Review of Precision Medicine and Drug Development·Amanda N LisbyScott A Waldman
May 27, 2021·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·H S AbboudS C Soares-Lima

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Imaging

Imaging techniques, including CT and MR, have become essential to tumor detection, diagnosis, and monitoring. Here is the latest research on cancer imaging.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.